EC
MD icon

EntryPoint Capital’s Pediatrix Medical MD Stock Holding History

EntryPoint Capital’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,010
Closed -$50.3K – 1325
2024
Q1 		$50.3K Sell
5,010
-3,184
-39% -$29.6K 0.05% 763
2023
Q4 		$76.2K Buy
+8,194
New +$84.8K 0.07% 521

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

EntryPoint Capital's MD Position: Q2 2024 in Review

EntryPoint Capital sold out of Pediatrix Medical (MD) in Q2 2024, closing a stake of 5,010 shares — an estimated $50.3K sold.

EntryPoint Capital first reported a position in MD in Q4 2023 and held it in 2 quarters. The position peaked at $76.2K in Q4 2023. 227 funds tracked by Wall St. Rank hold MD as of Q2 2024.

  • EntryPoint Capital reported no remaining Pediatrix Medical position as of Q2 2024 after selling out during the quarter.
  • EntryPoint Capital sold 5,010 Pediatrix Medical shares in Q2 2024, an estimated $50.3K.
  • EntryPoint Capital first reported a position in Pediatrix Medical in Q4 2023 and held it in 2 quarters.
  • EntryPoint Capital's Pediatrix Medical position peaked at $76.2K in Q4 2023.
  • 227 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2024.

Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.